Views & Analysis Ensuring access: how to help patients seeking experimental t... The impact of the debate on the Right-to-Try laws in the US and what needs to be done to improve access to innovative drugs.
News ABPI's judicial review could be pointless - lawyer Lawyer warns that NICE could reinstate cost measures after review
Views & Analysis Dr. B: Expanding the business model from COVID vaccines to a... Cyrus Massoumi, founder of Dr.
Market Access UK life science competitiveness indicators 2022: measuring w... The latest life science competitiveness indicators (LSCIs
Views & Analysis How can the pharma industry navigate issues in the global su... Supply chain shortages have dominated headlines for several months, and the pharma industry has been no exception.
News Lilly's 'triple G' retatrutide aces crucial obesity trial Lilly's retatrutide achieved weight loss of more than 30% at two years in a new trial, firming up its credentials as a next-generation obesity drug.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
